Category: E-Books

Fundamentals of Corporate Finance (11th Edition) - eBook
Sale!
Original price was: $68.00.Current price is: $12.00. $0.00
The best-selling Fundamentals of Corporate Finance, 11th edition (PDF/ePub) has three fundamental themes that are the central focus of the ebook: 1) A focus on intuition—the authors separate and describe the principles at work on a common-sense intuitive level before launching into any specifics. 2) A unified valuation approach—net present
Hutchison's Clinical Methods: An Integrated Approach to Clinical Practice (24th Edition) - eBook
Sale!
Original price was: $54.00.Current price is: $5.00. $0.00
Hutchison’s Clinical Methods: An Integrated Approach to Clinical Practice 24th Edition (PDF), first published more than a century ago, is the classic etextbook on clinical skills. It provides an outstanding source of learning and reference for postgraduate doctors and undergraduate medical students. It seeks to teach an integrated approach to
Trauma (9th Edition) - eBook
Sale!
Original price was: $168.99.Current price is: $26.00. $0.00
The world’s popular resource for diagnosing and treating any injury— safely, quickly, and effectively. Doody’s Core Titles for 2021! Unmatched in its breadth and depth of skillfully crafted content, Trauma 9th Edition (PDF) by Feliciano/Mattox/Moore takes you through the complete range of injuries you are likely to face. With a
Social Psychology (8th Edition) - eBook
Sale!
Original price was: $55.00.Current price is: $9.00. $0.00
The latest edition of this lively introduction, titled Social Psychology 8th Edition (PDF) by Hogg and Vaughan, places social psychology in a contemporary, real-world context and explores cutting-edge, new research as well as bringing classic theories to life. Thoroughly revised to enhance accessibility, and updated to include over 250 new references,
Statistics In the Pharmaceutical Industry (3rd Edition) - eBook
Sale!
Original price was: $140.00.Current price is: $21.00. $0.00
The advance of the pharmaceutical industry over the past decade is amazing, but the impact of this growth on statistics is somewhat puzzling. While the software has made analysis easier and more efficient, regulatory bodies now insist on deeper and more complicated analyses, and pharmacogenetic/genomic studies serve up a completely